Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
US Brand Name
Fam-trastuzumab deruxtecan-nxki injection is used to treat HER2-positive metastatic breast cancer (cancer that has spread) or whose cancer cannot be removed with surgery in patients who have previously received two or more anti-HER2-based regimens in the metastatic setting.
HER2 protein is produced by some breast tumors. Fam-trastuzumab deruxtecan-nxki interferes with the growth of this protein which also prevents tumor growth. The tumor cells will then be destroyed by the body.
This medicine is to be given only by or under the immediate supervision of your doctor.
This product is available in the following dosage forms: